NEW YORK (GenomeWeb) – Thermo Fisher Scientific said yesterday that it has priced an offering of $1.5 billion aggregate principal amount of senior notes.

The company is aiming to raise $750 million through the issuance of its 3.2% senior notes due 2027 and $750 million aggregate principal amount through the issuance of its 4.1% senior notes due 2047.

The issuance of the notes is expected to close on Aug. 14, and the notes will pay interest on a semi-annual basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.